SCHEDULES
C1SCHEDULE 31Sampling
Notice to person named on container
14
1
This paragraph applies where the sampling officer has obtained a sample of a substance or article and it appears to the sampling officer that—
a
the substance or article was manufactured in the United Kingdom by a person (“M”) whose name and address in the United Kingdom are stated on its container or packaging; and
b
M is not a person to whom a part of the sample must be supplied under the preceding provisions of this Schedule.
2
Unless the sampling officer decides not to submit the sample for analysis or other examination, the sampling officer must give notice to M—
a
stating that the sample has been obtained; and
b
specifying the person from whom the sampling officer purchased it or, if it was obtained otherwise than by purchase, the place from which the sampling officer obtained it.
3
Notice under sub-paragraph (2) must be given to M within the period of three days beginning immediately after the day on which the sample was obtained.
Sch. 31 applied (with modifications) by The Medicines for Human Use (Clinical Trials) Regulations 2004 (S.I. 2004/1031), reg 47(1), Sch. 9 (as substituted (14.8.2012) by S.I. 2012/1916, reg. 1(2), Sch. 34 paras. 57(b), 64 (with Sch. 32))